Moreover, data from The Cancer Genome Atlas (TCGA) were utilized to investigate the effect of SLC7A11 expression on the tumor microenvironment (TME), the tumor mutation burden (TMB), and the drug sensitivity. The gene discussed is SLC7A11; the disease is neoplasm.